☰

Cynthia L. de la Fuente, Ph.D. - Publications

Affiliations: 
2006 The George Washington University, Washington, DC, United States 
Area:
Molecular Biology, Biochemistry, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Fitzpatrick CJ, Mudhasani RR, Altamura LA, Campbell CE, Tran JP, Beitzel BF, Narayanan A, de la Fuente CL, Kehn-Hall K, Smith JM, Schmaljohn CS, Garrison AR. Junin Virus Activates p38 MAPK and HSP27 Upon Entry. Frontiers in Cellular and Infection Microbiology. 12: 798978. PMID 35463647 DOI: 10.3389/fcimb.2022.798978  0.426
2022 Bracci N, de la Fuente C, Saleem S, Pinkham C, Narayanan A, García-Sastre A, Balaraman V, Richt JA, Wilson W, Kehn-Hall K. Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production. Virology. 567: 65-76. PMID 35032865 DOI: 10.1016/j.virol.2021.12.010  0.347
2018 Bell TM, Espina V, Lundberg L, Pinkham C, Brahms A, Carey BD, Lin SC, Dahal B, Woodson C, de la Fuente C, Liotta LA, Bailey CL, Kehn-Hall K. Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication. Viruses. 10. PMID 29652799 DOI: 10.3390/v10040191  0.321
2018 de la Fuente C, Pinkham C, Dabbagh D, Beitzel B, Garrison A, Palacios G, Hodge KA, Petricoin EF, Schmaljohn C, Campbell CE, Narayanan A, Kehn-Hall K. Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection. Plos One. 13: e0191983. PMID 29408900 DOI: 10.1371/journal.pone.0191983  0.387
2017 Pinkham C, Dahal B, de la Fuente CL, Bracci N, Beitzel B, Lindquist M, Garrison A, Schmaljohn C, Palacios G, Narayanan A, Campbell CE, Kehn-Hall K. Alterations in the host transcriptome in vitro following Rift Valley fever virus infection. Scientific Reports. 7: 14385. PMID 29085037 DOI: 10.1038/s41598-017-14800-3  0.344
2017 Bell TM, Espina V, Senina S, Woodson C, Brahms A, Carey B, Lin SC, Lundberg L, Pinkham C, Baer A, Mueller C, Chlipala EA, Sharman F, de la Fuente C, Liotta L, et al. Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis. Antiviral Research. PMID 28442428 DOI: 10.1016/J.Antiviral.2017.04.011  0.37
2016 Lundberg L, Pinkham C, de la Fuente C, Brahms A, Shafagati N, Wagstaff KM, Jans DA, Tamir S, Kehn-Hall K. Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells. Plos Neglected Tropical Diseases. 10: e0005122. PMID 27902702 DOI: 10.1371/journal.pntd.0005122  0.333
2016 Kendra JA, de la Fuente C, Brahms A, Woodson C, Bell TM, Chen B, Khan YA, Jacobs JL, Kehn-Hall K, Dinman JD. Ablation of programmed -1 ribosomal frameshifting in Venezuelan equine encephalitis virus results in attenuated neuropathogenicity. Journal of Virology. PMID 27852852 DOI: 10.1128/Jvi.01766-16  0.349
2015 Benedict A, Bansal N, Senina S, Hooper I, Lundberg L, de la Fuente C, Narayanan A, Gutting B, Kehn-Hall K. Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection. Frontiers in Microbiology. 6: 676. PMID 26217313 DOI: 10.3389/fmicb.2015.00676  0.354
2015 Cyr N, de la Fuente C, Lecoq L, Guendel I, Chabot PR, Kehn-Hall K, Omichinski JG. A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence. Proceedings of the National Academy of Sciences of the United States of America. 112: 6021-6. PMID 25918396 DOI: 10.1073/Pnas.1503688112  0.39
2014 Madsen C, Hooper I, Lundberg L, Shafagati N, Johnson A, Senina S, de la Fuente C, Hoover LI, Fredricksen BL, Dinman J, Jacobs JL, Kehn-Hall K. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication. Antiviral Research. 112: 26-37. PMID 25448087 DOI: 10.1016/J.Antiviral.2014.10.002  0.343
2014 Amaya M, Voss K, Sampey G, Senina S, de la Fuente C, Mueller C, Calvert V, Kehn-Hall K, Carpenter C, Kashanchi F, Bailey C, Mogelsvang S, Petricoin E, Narayanan A. The role of IKKβ in Venezuelan equine encephalitis virus infection. Plos One. 9: e86745. PMID 24586253 DOI: 10.1371/Journal.Pone.0086745  0.617
2007 Berro R, de la Fuente C, Klase Z, Kehn K, Parvin L, Pumfery A, Agbottah E, Vertes A, Nekhai S, Kashanchi F. Identifying the membrane proteome of HIV-1 latently infected cells. The Journal of Biological Chemistry. 282: 8207-18. PMID 17237230 DOI: 10.1074/Jbc.M606324200  0.727
2006 Pumfery A, de la Fuente C, Kashanchi F. HTLV-1 Tax: centrosome amplification and cancer. Retrovirology. 3: 50. PMID 16899128 DOI: 10.1186/1742-4690-3-50  0.593
2006 de la Fuente C, Gupta MV, Klase Z, Strouss K, Cahan P, McCaffery T, Galante A, Soteropoulos P, Pumfery A, Fujii M, Kashanchi F. Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approach. Retrovirology. 3: 43. PMID 16822311 DOI: 10.1186/1742-4690-3-43  0.746
2006 Pumfery A, de la Fuente C, Berro R, Nekhai S, Kashanchi F, Chao SH. Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics. Current Pharmaceutical Design. 12: 1949-61. PMID 16787240 DOI: 10.2174/138161206777442083  0.761
2006 Berro R, Kehn K, de la Fuente C, Pumfery A, Adair R, Wade J, Colberg-Poley AM, Hiscott J, Kashanchi F. Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. Journal of Virology. 80: 3189-204. PMID 16537587 DOI: 10.1128/Jvi.80.7.3189-3204.2006  0.775
2005 Liang WS, Maddukuri A, Teslovich TM, de la Fuente C, Agbottah E, Dadgar S, Kehn K, Hautaniemi S, Pumfery A, Stephan DA, Kashanchi F. Therapeutic targets for HIV-1 infection in the host proteome. Retrovirology. 2: 20. PMID 15780141 DOI: 10.1186/1742-4690-2-20  0.649
2005 Agbottah E, de La Fuente C, Nekhai S, Barnett A, Gianella-Borradori A, Pumfery A, Kashanchi F. Antiviral activity of CYC202 in HIV-1-infected cells. The Journal of Biological Chemistry. 280: 3029-42. PMID 15531588 DOI: 10.1074/Jbc.M406435200  0.685
2004 Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, Kashanchi F. Role of viral regulatory and accessory proteins in HIV-1 replication. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2388-413. PMID 15353294 DOI: 10.2741/1403  0.785
2004 Kehn K, Berro R, de la Fuente C, Strouss K, Ghedin E, Dadgar S, Bottazzi ME, Pumfery A, Kashanchi F. Mechanisms of HTLV-1 transformation. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2347-72. PMID 15353292 DOI: 10.2741/1401  0.749
2004 Lacoste V, de la Fuente C, Kashanchi F, Pumfery A. Kaposi's sarcoma-associated herpesvirus immediate early gene activity. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2245-72. PMID 15353285 DOI: 10.2741/1394  0.533
2004 de la Fuente C, Kashanchi F. The expanding role of Tax in transcription. Retrovirology. 1: 19. PMID 15285790 DOI: 10.1186/1742-4690-1-19  0.544
2004 Kehn K, Deng L, de la Fuente C, Strouss K, Wu K, Maddukuri A, Baylor S, Rufner R, Pumfery A, Bottazzi ME, Kashanchi F. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology. 1: 6. PMID 15169570 DOI: 10.1186/1742-4690-1-6  0.66
2004 Ghedin E, Pumfery A, de la Fuente C, Yao K, Miller N, Lacoste V, Quackenbush J, Jacobson S, Kashanchi F. Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis. Retrovirology. 1: 10. PMID 15169557 DOI: 10.1186/1742-4690-1-10  0.64
2004 Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F. Protein profile of tax-associated complexes. The Journal of Biological Chemistry. 279: 495-508. PMID 14530271 DOI: 10.1074/Jbc.M310069200  0.651
2003 Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD, Lambert P, Kumar A, Kashanchi F. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Current Hiv Research. 1: 343-62. PMID 15046258 DOI: 10.2174/1570162033485186  0.635
2003 de la Fuente C, Maddukuri A, Kehn K, Baylor SY, Deng L, Pumfery A, Kashanchi F. Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics. Current Hiv Research. 1: 131-52. PMID 15043199 DOI: 10.2174/1570162033485339  0.703
2003 de la Fuente C, Wang L, Wang D, Deng L, Wu K, Li H, Stein LD, Denny T, Coffman F, Kehn K, Baylor S, Maddukuri A, Pumfery A, Kashanchi F. Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Molecular and Cellular Biochemistry. 245: 99-113. PMID 12708749 DOI: 10.1023/A:1022866027585  0.568
2002 Wang L, Deng L, Wu K, de la Fuente C, Wang D, Kehn K, Maddukuri A, Baylor S, Santiago F, Agbottah E, Trigon S, Morange M, Mahieux R, Kashanchi F. Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors. Molecular and Cellular Biochemistry. 237: 137-53. PMID 12236581 DOI: 10.1023/A:1016555821581  0.613
2002 de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. Bmc Biochemistry. 3: 14. PMID 12069692 DOI: 10.1186/1471-2091-3-14  0.648
Show low-probability matches.